STAT Summit 2019

Nov 20 & 21 Cambridge, MA #STATSUMMIT

Request Invitation


Catalyzing a revolution in human health

Biology is changing the world. For almost four years, STAT has been reporting from the frontiers of medicine like no other publication. Now, Matthew Herper, Editorial Director of Events, and the rest of the STAT team are assembling top executives and researchers, policymakers, and patient advocates to scout the future of medicine — the biggest advances and the emerging challenges — and identify ways to push the limits of what’s possible for human health.

Request Invitation


Hear from these industry-shaping speakers

  • Hal Barron, M.D.

    Hal Barron, M.D.

    Chief Scientific Officer and President, R&D, GlaxoSmithKline

  • Arie Belldegrun, M.D., F.A.C.S.
    Sponsor Speaker

    Arie Belldegrun, M.D., F.A.C.S.

    Executive Chairman and Co-Founder, Allogene Therapeutics

  • Dr. Morris Birnbaum
    Sponsor Speaker

    Dr. Morris Birnbaum

    SVP and Chief Scientific Officer, Pfizer

  • Jason Bock, Ph.D.
    Sponsor Speaker

    Jason Bock, Ph.D.

    Vice President, Therapeutics Discovery, Head of Biologics Product Development, The University of Texas MD Anderson Cancer Center

  • Otis W. Brawley, M.D.

    Otis W. Brawley, M.D.

    Bloomberg Distinguished Professor of Oncology and Epidemiology, Johns Hopkins University

  • Giovanni Caforio, M.D.

    Giovanni Caforio, M.D.

    Chairman and CEO, Bristol-Myers Squibb

  • Matthew J. Carty, M.D.

    Matthew J. Carty, M.D.

    Director, Lower Extremity Reconstruction Program, Brigham Health; Staff Surgeon, Division of Plastic Surgery, Brigham Health; Associate Professor, Harvard Medical School

  • Patrick Dey
    Sponsor Speaker

    Patrick Dey

    Vice President Digital Health & Innovation, Amgen

  • David Fajgenbaum, M.D., M.B.A, M.Sc.

    David Fajgenbaum, M.D., M.B.A, M.Sc.

    Co-Founder & Executive Director, Castleman Disease Collaborative Network

  • Jacqualyn Fouse, Ph.D.

    Jacqualyn Fouse, Ph.D.

    CEO, Agios Pharmaceuticals

  • Janet Freeman-Daily

    Janet Freeman-Daily

    Lung Cancer Patient/Activist,

  • Laurie H. Glimcher, M.D.

    Laurie H. Glimcher, M.D.

    President and CEO, Dana-Farber Cancer Institute

  • Katherine A. High, M.D.

    Katherine A. High, M.D.

    President and Head of Research and Development, Spark Therapeutics

  • Jeff Jonas, M.D.

    Jeff Jonas, M.D.

    Chief Executive Officer, Sage Therapeutics

  • Philip Jones, Ph.D.
    Sponsor Speaker

    Philip Jones, Ph.D.

    Vice President, Therapeutics Discovery, Head of Drug Discovery, The University of Texas MD Anderson Cancer Center

  • Daphne Koller, Ph.D.

    Daphne Koller, Ph.D.

    Founder and CEO, Insitro

  • Jeffrey Leiden, M.D., Ph.D.

    Jeffrey Leiden, M.D., Ph.D.

    CEO, Vertex Pharmaceuticals

  • Matthew Might, Ph.D.

    Matthew Might, Ph.D.

    Director, Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham

  • Dr. Lloyd Minor

    Dr. Lloyd Minor

    Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine

  • Mark Namchuk, Ph.D.
    Sponsor Speaker

    Mark Namchuk, Ph.D.

    SVP Research, Pharmaceutical and Non-clinical Development, Alkermes

  • Steven E. Nissen, M.D., M.A.C.C.

    Steven E. Nissen, M.D., M.A.C.C.

    Chief Academic Officer for the Heart and Vascular Institute, Cleveland Clinic

  • Daniel O'Day

    Daniel O'Day

    Chairman and Chief Executive Officer, Gilead Sciences

  • Gianluca Pirozzi, M.D. Ph.D.
    Sponsor Speaker

    Gianluca Pirozzi, M.D. Ph.D.

    Head of Development for Rare Diseases and Translational Gene Therapy, Sanofi

  • Aviv Regev, Ph.D.

    Aviv Regev, Ph.D.

    HHMI, MIT and Core Institute Member and Chair of the Faculty, Broad Institute of MIT and Harvard

  • Ramona Sequeira
    Sponsor Speaker

    Ramona Sequeira

    President, United States Business Unit, Takeda

  • Stephen J. Ubl
    Sponsor Speaker

    Stephen J. Ubl

    President and CEO, PhRMA

  • Check back in as we continue to add more speakers!

Apply today to be considered for speaking opportunities at this event, and others like it. Apply to present.


Defining the future of health and medicine

We'll cover everything from the pharmacy to the lab bench, including the emerging role of AI in drug development and novel ideas for how America can pay for costly new medicines.

  • Nov20


    Check-in, programming and welcome reception

  • Nov21


    Full-day programming and cocktail reception

  • Full Agenda

    It's still in motion! Here are the confirmed sessions.


MIT Campus

75 Amherst St., Cambridge, MA
Building E14, 6th Floor
View on Google Maps
Get Travel & Hotel Information

© Mapbox © OpenStreetMap


The most impactful health care event of the year

Space is limited! Request an invite to attend the 2019 STAT Summit.

Enjoy early bird pricing through June 30

Request Invitation

Questions? Contact us at



You're currently employed at a biotech or pharmaceutical company that falls outside the purview of startup, as defined below



Companies who are still in their Series A or B funding rounds, and/or who are working out of incubator space



External companies and firms that provide a service to biotech, pharma, and life sciences companies



You must register with your nonprofit/government email address to qualify for this rate

Request Invitation

Question? Contact us at


A special thanks to our partners

Presenting Sponsor

STAT Wunderkinds Sponsor

STAT Biomedical Innovation
Award Sponsor

Premium Sponsors

Supporting Sponsors


Stay in the loop

Join our email list

Sign up today for summit news and updates

Please enter a valid email address.


Email us any questions or concerns

Terms & Conditions